普罗吉尼生育健康 PGNY
$34.84 +$0.47 (+1.37%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $34.70 -0.40%
开盘$33.67
昨收$34.37
当日区间$33.34 – $34.90
成交量1.55M
市值$2.57B
市盈率（TTM）32.0
股息率–
PGNY 相关新闻
匹配 Progyny 或代码 PGNY 的头条新闻，按最新排序。
- Citizens JMP Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $33 正面
- A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $31 to $35
- Barclays Maintains Progyny(PGNY.US) With Hold Rating, Maintains Target Price $34
- CCORF Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $35 负面
- BofA Securities Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $31
- J.P. Morgan Maintains Progyny(PGNY.US) With Hold Rating, Raises Target Price to $30 正面
- Wells Fargo Initiates Progyny(PGNY.US) With Buy Rating, Announces Target Price $37
- Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $36
- Barclays Maintains Progyny(PGNY.US) With Hold Rating, Cuts Target Price to $30 负面
- CCORF Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $35
- Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Progyny (PGNY) and Adicet Bio (ACET)
- Barclays Downgrades Progyny(PGNY.US) to Hold Rating, Raises Target Price to $34 中性
- BTIG Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $40 正面
- CCORF Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $36 正面
- Leerink Partners Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $38
暂无评论——快来第一个聊聊 PGNY。
登录后参与讨论。